Drug intelligence / Profile preview

licochalcone A + decanediol + L-carnitine + salicylic acid

Development stage
Unknown
Lead developer
Beiersdorf
Modality
Small Molecules
Administration
Topical
01

Overview

This combination is a topical dermatological formulation primarily developed by Beiersdorf for the treatment of acne-prone skin. It utilizes a multi-modal approach to address the four key factors of acne: hyperkeratosis, seborrhea, microbial colonization, and inflammation. Salicylic acid acts as a keratolytic agent to unclog pores and reduce blemishes; L-carnitine regulates sebum production by promoting fatty acid oxidation within sebocytes; Decanediol (1,2-decanediol) provides targeted antibacterial activity against *Cutibacterium acnes*; and Licochalcone A, a flavonoid derived from licorice root (*Glycyrrhiza inflata*), serves as a potent anti-inflammatory and antioxidant agent to soothe irritation and reduce redness. The formulation is designed to improve skin clarity and texture while minimizing the risk of irritation often associated with intensive acne treatments.

Brand names
Eucerin DermoPurifyer Oil Control Skin Renewal TreatmentEucerin DermoPure Skin Renewal Treatment
02

Targets

SLC7A1 (Cationic amino acid transporter 1)

Beyond the preview

Go deeper on licochalcone A + decanediol + L-carnitine + salicylic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on licochalcone A + decanediol + L-carnitine + salicylic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call